INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 29, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 9,386 | $145.44 | 65,119 |
| Aug 05, 2022 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 2,022 | $611.44 | 66,070 |
| Jan 05, 2005 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 63,234 | -- | 66,666 |
| Nov 20, 2012 |
SVP Res and Devel Sciences
|
SVP Res and Devel Sciences | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 7,694 | $167.17 | 66,719 |
| Sep 07, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Open market or private sale of non-derivative or derivative security | 8,286 | $69.58 | 67,251 |
| Nov 14, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 17,182 | $11.64 | 67,532 |
| Aug 05, 2022 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 3,931 | $610.49 | 68,092 |
| Dec 16, 2015 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 68,638 | -- | 68,638 |
| Feb 14, 2012 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 50,000 | -- | 69,048 |
| Aug 05, 2022 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Open market or private sale of non-derivative or derivative security | 3,044 | $609.62 | 72,023 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.